A novel use of recombinant factor VIIa in HELLP syndrome associated with spontaneous hepatic rupture and abdominal compartment syndrome.
Department of Surgery, Division of Surgical Critical Care, University of Tennessee College of Medicine, Chattanooga Unit, Chattanooga, Tennessee 37403, USA.
Benjamin W
BW
Dart
W Todd
WT
Cockerham
Carlos
C
Torres
Joseph H
JH
Kipikasa
Robert A
RA
Maxwell
D000328:Adult; D003161:Compartment Syndromes / Q000150:complications / Q000628:therapy*; D019299:Decompression, Surgical; D003937:Diagnosis, Differential; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D005260:Female; D017359:HELLP Syndrome / Q000150:complications / Q000628:therapy*; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000628:therapy*; D017713:Platelet Transfusion; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011994:Recombinant Proteins / Q000627:therapeutic use*; D012422:Rupture, Spontaneous
D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa